Record Q3 Silver Production, But Sustainability Still Unproven

What happened

Aya Gold & Silver reported a record Q3-2026 production of 2.03 million silver equivalent ounces from its Zgounder Silver Mine, marking a significant step-up from prior quarters and suggesting the expanded mill is hitting higher throughput. The release also highlights advancement of the Boumadine pyrite reclaim operation, which adds optionality but remains early-stage. However, a single record quarter does not confirm the sustained ~3,650 tpd throughput, ~90% recoveries, and ~$21.50/oz cash cost that the current valuation assumes. Management's own 2026 guidance remains 5.2–5.8 Moz from Zgounder, implying the Q3 run-rate may not be repeatable over the full year. Investors should treat this headline as supportive of operational momentum but await cost and recovery data before concluding that free cash flow will match the base-case scenario.

Implication

The Q3 record strengthens the bull case that Zgounder can exceed the 3,650 tpd sustained rate, but it does not by itself address the key risk of cost creep above $21.50/oz or feed stability from open-pit material movement near 38,814 tpd. Investors should focus on the upcoming Q3 financials for evidence on cash costs and recoveries, as well as any updates on Boumadine's resource update scheduled for H2-2026. If two consecutive quarters show throughput above guidance with costs below $20/oz, the thesis would shift to a stronger buy; conversely, if costs rise or throughput falls back, the stock could re-rate toward the bear-case $18. The current price of $26.03 is above the attractive entry of $22 and below the trim above $32, so no action is warranted until more data emerges. Position sizing should remain moderate given the high capital and exploration spend planned for 2026 and the pending DF arbitration overhang.

Thesis delta

The production record slightly increases confidence in Zgounder's operational capability but does not change the core thesis that the market is paying for repeatable ~3,650 tpd and ~90% recoveries at ~$21.50/oz cash cost. One strong quarter is insufficient to validate the cost and throughput assumptions; we need two consecutive quarters of evidence. The Boumadine update remains a key catalyst, but the current valuation still offers no margin of safety, so the WAIT rating stands.